A PYMNTS Company

EU: In-depth probe opened into Zimmer, Biomet merger

By  |  October 5, 2014

US medical device company Zimmer is facing an in-depth probe by competition authorities in Europe over its proposed buyout of Biomet for $13.4 billion, reports say.

The European Commission said Friday it opened a formal investigation of the transaction to pressure Zimmer into offering concessions to secure regulatory clearance for the buyout. Reports say following the takeover, Zimmer will become the world’s second-largest seller of orthopedic products behind Johnson & Johnson.

The Commission will reportedly rule on the deal by February 16 of next year.

Full content: Reuters

Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.